488 related articles for article (PubMed ID: 29627066)
1. Treatment of hepatocellular carcinoma in the caudate lobe: US-guided percutaneous radiofrequency ablation combined with ethanol ablation.
Liu B; Long J; Wang W; Huang G; Jiang C; Zhang X; Liu M; Liang P; Yu J; Xie X; Kuang M
Clin Radiol; 2018 Jul; 73(7):647-656. PubMed ID: 29627066
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
[TBL] [Abstract][Full Text] [Related]
3. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
[TBL] [Abstract][Full Text] [Related]
4. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm.
Yan JY; Zhang JL; Wang MQ; Yuan K; Bai YH; Wang Y; Xin HN; Wang ZJ; Liu FY; Duan F; Fu JX
Asia Pac J Clin Oncol; 2018 Aug; 14(4):300-309. PubMed ID: 29124894
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe.
Lee BC; Liu KL; Wu CH; Huang KW; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH; Liang PC
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1699-1707. PubMed ID: 29946941
[TBL] [Abstract][Full Text] [Related]
7. Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation.
Kim SS; Kang TW; Kim M; Lee MW; Cho SK; Paik YH; Kim MJ
Clin Radiol; 2018 Feb; 73(2):216.e1-216.e8. PubMed ID: 28859852
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: a retrospective study.
Liu B; Long J; Wang W; Huang T; Xie X; Chen S; Huang G; Jiang C; Ye J; Long H; Xie X; Kuang M
BMC Cancer; 2019 Jul; 19(1):699. PubMed ID: 31311502
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Combined Therapy Using Conventional Chemoembolization and Radiofrequency Ablation Versus Conventional Chemoembolization for Ultrasound-Invisible Early-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Cancer Stage 0 or A).
Lee H; Yoon CJ; Seong NJ; Jeong SH; Kim JW
Korean J Radiol; 2018; 19(6):1130-1139. PubMed ID: 30386144
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided radiofrequency ablation in the treatment of solitary large hepatocellular carcinoma.
Yuan H; Liu F; Li X; Guan Y; Wang M
Radiol Med; 2019 Jan; 124(1):1-7. PubMed ID: 30132184
[TBL] [Abstract][Full Text] [Related]
11. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience.
Huang J; Xie X; Lin J; Wang W; Zhang X; Liu M; Li X; Huang G; Liu B; Xie X
Cancer Imaging; 2019 Jun; 19(1):44. PubMed ID: 31242934
[TBL] [Abstract][Full Text] [Related]
13. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.
Gui CH; Baey S; D'cruz RT; Shelat VG
Eur J Surg Oncol; 2020 May; 46(5):763-771. PubMed ID: 31937433
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma originating in the caudate lobe: A pilot clinical study.
Peng Y; Cui D; Li W; Ding M; Shi Y; Wang T; Shi D; Chi J; Li P; Zhai B
J Cancer Res Ther; 2021 Jul; 17(3):764-770. PubMed ID: 34269311
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation for viable hepatocellular carcinoma around retained iodized oil after transcatheter arterial chemoembolization: usefulness of biplane fluoroscopy plus ultrasound guidance.
Min JH; Lee MW; Rhim H; Choi D; Kim YS; Kim YJ; Cha DI; Lim HK
Korean J Radiol; 2012; 13(6):784-94. PubMed ID: 23118578
[TBL] [Abstract][Full Text] [Related]
16. Impact of an ultrasound-guided radiofrequency ablation training program on the outcomes in patients with hepatocellular carcinoma.
Takai Takamatsu R; Okano A; Yamakawa G; Mizukoshi K; Obayashi H; Ohana M
Diagn Interv Imaging; 2019 Dec; 100(12):771-780. PubMed ID: 31477516
[TBL] [Abstract][Full Text] [Related]
17. Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma.
Lee SY; Hyun D; Cho SK; Shin SW; Jung SH; Chi SA
Cardiovasc Intervent Radiol; 2018 Jan; 41(1):120-129. PubMed ID: 28924943
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.
Min JH; Lee MW; Cha DI; Jeon YH; Shin SW; Cho SK; Rhim H; Lim HK
Korean J Radiol; 2013; 14(2):248-58. PubMed ID: 23483753
[TBL] [Abstract][Full Text] [Related]
19. [Curative effect analysis of ultrasound-guided percutaneous radiofrequency ablation for caudate lobe hepatocellular carcinoma].
Zhou YZ; Zhu RL; Wang ZZ; Yu KL; Li QJ; Zhou JX
Zhonghua Gan Zang Bing Za Zhi; 2021 Jul; 29(7):690-695. PubMed ID: 34371541
[No Abstract] [Full Text] [Related]
20. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
Kim JH; Kim PN; Won HJ; Shin YM
AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
